Teladoc Health (TDOC) Stock Price, News & Analysis

Company Overview

Teladoc Health, Inc. is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease. The company also provides integrated virtual care solutions that combine live consultations with remote patient monitoring devices, enabling continuous health tracking and proactive intervention. In 2020, Teladoc expanded its capabilities through the acquisition of Livongo Health, a leader in digital chronic condition management, thereby strengthening its population health offerings.

With headquarters in Purchase, New York, Teladoc operates in more than 175 countries and serves a diverse client base that includes employers, health plans, hospitals, and health systems. The company maintains regional operations in North America, Latin America, Europe, and the Asia Pacific region, adapting services to meet local regulatory requirements and healthcare needs. Strategic partnerships with insurers and healthcare providers help Teladoc integrate virtual care into existing care pathways and insurance networks.

Founded in 2002 by Michael Gorton and Byron Brooks, Teladoc has evolved from a telephonic medical consultation service into a comprehensive virtual care platform. Jason Gorevic has served as Chief Executive Officer since 2009, guiding the company through rapid expansion, technology innovation, and multiple acquisitions. Under his leadership, Teladoc continues to invest in digital health solutions, artificial intelligence, and data-driven tools to support the future of connected care.

Key Stats

• Today's Range: $7.90 to $8.30
• 50-Day Range: $6.79 to $8.55
• 52-Week Range: $6.35 to $15.21
• Volume: 6.31 million shs
• Average Volume: 4.20 million shs
• Market Capitalization: $1.40 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.80
• Consensus Rating: Hold

Teladoc Health Stock Analysis - MarketRank™

Teladoc Health scored higher than 48% of companies evaluated by MarketBeat, and ranked 570th out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Hold

Consensus Rating

Teladoc Health has received a consensus rating of Hold. The company's average rating score is 2.35, and is based on 6 buy ratings, 11 hold ratings, and no sell ratings.

Upside Potential

Teladoc Health has a consensus price target of $9.80, representing about 23.5% upside from its current price of $7.93.

Amount of Analyst Coverage

Teladoc Health has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Teladoc Health are expected to grow in the coming year, from ($1.16) to ($0.98) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Teladoc Health is -6.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Teladoc Health is -6.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Teladoc Health has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

13.10% of the float of Teladoc Health has been sold short.

Short Interest Ratio / Days to Cover

Teladoc Health has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Teladoc Health has recently decreased by 2.54%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Teladoc Health does not currently pay a dividend.

Dividend Growth

Teladoc Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

13.10% of the float of Teladoc Health has been sold short.

Short Interest Ratio / Days to Cover

Teladoc Health has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Teladoc Health has recently decreased by 2.54%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

News Sentiment

Teladoc Health has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.

Search Interest

Only 32 people have searched for TDOC on MarketBeat in the last 30 days. This is a decrease of -3% compared to the previous 30 days.

MarketBeat Follows

5 people have added Teladoc Health to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Teladoc Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.58% of the stock of Teladoc Health is held by insiders.

Percentage Held by Institutions

76.82% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

TDOC Stock Analysis - Frequently Asked Questions

How have TDOC shares performed this year?

Teladoc Health's stock was trading at $9.09 at the beginning of 2025. Since then, TDOC stock has decreased by 12.8% and is now trading at $7.93.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) issued its quarterly earnings results on Tuesday, July, 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. Teladoc Health's quarterly revenue was down 1.6% compared to the same quarter last year.
Read the conference call transcript.

Does Teladoc Health have any subsidiaries?

Teladoc Health subsidiaries include these companies: Livongo, Intouch Health, MedecinDirect, TelaDietitian, Advance Medical, Best Doctors, CogCubed, and more.

When did Teladoc Health IPO?

Teladoc Health (TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who are Teladoc Health's major shareholders?

Teladoc Health's top institutional shareholders include Geode Capital Management LLC (2.35%), Maple Rock Capital Partners Inc. (1.52%), Ameriprise Financial Inc. (1.16%) and Connor Clark & Lunn Investment Management Ltd. (0.86%). Insiders that own company stock include Jason N Gorevic, Laizer Kornwasser, Mala Murthy, Michael Willem Waters, Nikolaos P Nanis, Adam C Vandervoort, Stephany Verstraete, Arnnon Geshuri, Andrew Turitz, Thomas Mckinley, Karen L Daniel, Vidya Raman-Tangella, Daniel Trencher, Richard J Napolitano, Carlos Nueno, James L Cave, Claus Torp Jensen and Fernando M Rodrigues.
View institutional ownership trends.

How do I buy shares of Teladoc Health?

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Teladoc Health investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Salesforce (CRM), Advanced Micro Devices (AMD) and PayPal (PYPL).

Company Calendar

• Last Earnings: 7/29/2025
• Today: 9/21/2025
• Next Earnings (Estimated): 10/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:TDOC
• CIK: 1477449
• Web: www.teladochealth.com
• Phone: (203) 635-2002
• Fax: N/A
• Employees: 5,500
• Year Founded: 2002

Price Target and Rating

• Average Price Target for Teladoc Health: $9.80
• High Price Target: $12.00
• Low Price Target: $7.00
• Potential Upside/Downside: +23.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.35
• Research Coverage: 17 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.00 billion
• Net Margins: -8.16%
• Pretax Margin: -9.14%
• Return on Equity: -10.13%
• Return on Assets: -4.43%

Debt

• Debt-to-Equity Ratio: 0.70
• Current Ratio: 2.67
• Quick Ratio: 2.58

Sales & Book Value

• Annual Sales: $2.57 billion
• Price / Sales: 0.55
• Cash Flow: $5.58 per share
• Price / Cash Flow: 1.42
• Book Value: $8.66 per share
• Price / Book: 0.92

Miscellaneous

• Outstanding Shares: 176,690,000
• Free Float: 175,666,000
• Market Cap: $1.40 billion
• Optionable: Optionable
• Beta: 1.84